ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 52 filers reported holding ARBUTUS BIOPHARMA CORP in Q1 2017. The put-call ratio across all filers is 25.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $357,562 | -15.9% | 176,139 | -4.7% | 0.00% | – |
| Q2 2023 | $425,282 | -62.4% | 184,905 | -50.5% | 0.00% | – |
| Q1 2023 | $1,131,506 | +162.2% | 373,434 | +101.6% | 0.00% | – |
| Q4 2022 | $431,535 | +20.9% | 185,208 | -0.8% | 0.00% | – |
| Q3 2022 | $357,000 | -19.4% | 186,776 | +14.4% | 0.00% | – |
| Q2 2022 | $443,000 | -9.4% | 163,307 | -0.5% | 0.00% | – |
| Q1 2022 | $489,000 | – | 164,130 | +16412900.0% | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 1 | -99.7% | 0.00% | – |
| Q1 2021 | $1,000 | -99.2% | 300 | -98.4% | 0.00% | – |
| Q3 2017 | $119,000 | +72.5% | 19,200 | 0.0% | 0.00% | – |
| Q2 2017 | $69,000 | +11.3% | 19,200 | 0.0% | 0.00% | – |
| Q1 2017 | $62,000 | +31.9% | 19,200 | 0.0% | 0.00% | – |
| Q4 2016 | $47,000 | -28.8% | 19,200 | 0.0% | 0.00% | – |
| Q3 2016 | $66,000 | -1.5% | 19,200 | 0.0% | 0.00% | – |
| Q2 2016 | $67,000 | -15.2% | 19,200 | 0.0% | 0.00% | – |
| Q1 2016 | $79,000 | -7.1% | 19,200 | 0.0% | 0.00% | – |
| Q4 2015 | $85,000 | +19.7% | 19,200 | +65.5% | 0.00% | – |
| Q3 2015 | $71,000 | – | 11,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,705,128 | $10,300,000 | 4.44% |
| RTW INVESTMENTS, LP | 5,666,754 | $15,754,000 | 0.59% |
| COWEN AND COMPANY, LLC | 926,200 | $2,575,000 | 0.22% |
| Hudson Bay Capital Management LP | 850,000 | $2,363,000 | 0.05% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 1,774,915 | $4,934,000 | 0.03% |
| Point72 Asset Management, L.P. | 1,897,284 | $5,274,000 | 0.03% |
| 683 Capital Management, LLC | 77,368 | $215,000 | 0.02% |
| Secure Asset Management, LLC | 10,000 | $28,000 | 0.02% |
| Qube Research & Technologies Ltd | 166,138 | $462,000 | 0.01% |
| Verition Fund Management LLC | 174,455 | $485,000 | 0.01% |